雜志介紹

Blood Advances雜志介紹

《Blood Advances》是一本以English為主的未開放獲取國際優秀期刊，中文名稱血液進展，本刊主要出版、報道醫學-HEMATOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為7.4，最新CiteScore 指數為12.7。

本刊近期中國學者發表的論文主要有：

• Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study

  Author: Qi, Shunan; Liu, Xin; Noy, Ariela; Lee, Jisun; Teckie, Sewit; Hajj, Carla; Joffe, Erel; Imber, Brandon S.; Yahalom, Joachim

英文介紹

Blood Advances雜志英文介紹

Blood Advances is a semimonthly medical journal published by the American Society of Hematology. It is the first journal to join the Blood family in 70 years and is a peer-reviewed, online only, open access journal. Under the direction of founding editor-in-chief Robert Negrin, MD, Stanford University Medical Center, Stanford, CA, the inaugural issue debuted on November 29, 2016.

Blood Advances provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. The journal covers all aspects of hematology, including disorders of leukocytes, both benign and malignant, erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology, and hematologic oncology. All articles undergo a rigorous peer-review and are selected on the basis of the originality of the findings, the superior quality of the work described, and the clarity of presentation.